Clinical Trials · NCT07605247
Tirzepatide in the Treatment of Endometrial Cancer
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Rutgers, The State University of New Jersey
- Enrollment
- 30
- Start date
- Jun 2026
- Locations
- See registry
- Primary endpoint
- Quality of Life Quality of life will be measured through PROMs at the time points listed below for explorative purposes.